COMITO, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 1.244
AS - Asia 1.232
EU - Europa 819
AF - Africa 106
Continente sconosciuto - Info sul continente non disponibili 77
SA - Sud America 60
OC - Oceania 2
Totale 3.540
Nazione #
US - Stati Uniti d'America 1.209
SG - Singapore 349
VN - Vietnam 346
CN - Cina 273
IT - Italia 260
GB - Regno Unito 98
DE - Germania 94
SE - Svezia 91
HK - Hong Kong 83
FR - Francia 54
NL - Olanda 52
CH - Svizzera 41
BR - Brasile 39
IN - India 39
IE - Irlanda 38
ZA - Sudafrica 34
CI - Costa d'Avorio 28
CA - Canada 24
RU - Federazione Russa 21
JP - Giappone 19
BD - Bangladesh 17
FI - Finlandia 17
NG - Nigeria 16
AT - Austria 15
KR - Corea 14
SC - Seychelles 13
TH - Thailandia 13
PH - Filippine 12
PK - Pakistan 10
TG - Togo 10
TR - Turchia 10
JO - Giordania 9
AR - Argentina 8
BE - Belgio 8
EC - Ecuador 8
ID - Indonesia 7
IQ - Iraq 7
UA - Ucraina 7
EE - Estonia 6
MX - Messico 5
TW - Taiwan 5
BG - Bulgaria 4
ES - Italia 4
SA - Arabia Saudita 4
PL - Polonia 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
IR - Iran 2
JM - Giamaica 2
LB - Libano 2
MA - Marocco 2
MY - Malesia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
GR - Grecia 1
GT - Guatemala 1
KG - Kirghizistan 1
LU - Lussemburgo 1
ME - Montenegro 1
MM - Myanmar 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PT - Portogallo 1
PY - Paraguay 1
SV - El Salvador 1
UZ - Uzbekistan 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.465
Città #
Singapore 250
Ashburn 158
Chandler 116
San Jose 92
Ho Chi Minh City 77
Hong Kong 76
Hanoi 73
Bologna 70
Southend 61
Fairfield 58
Santa Clara 56
Council Bluffs 41
Beijing 40
Dallas 40
Dublin 38
Woodbridge 37
Houston 34
Bern 33
Boardman 33
Hefei 31
Abidjan 28
Johannesburg 26
Los Angeles 26
Seattle 24
Princeton 23
Cambridge 22
Dong Ket 22
New York 19
Wilmington 18
Frankfurt am Main 16
Helsinki 16
Lauterbourg 16
Milan 16
Tokyo 16
Rome 13
Abeokuta 12
Da Nang 12
Haiphong 11
Seoul 11
Turin 11
Lomé 10
Redondo Beach 10
Amman 9
Ann Arbor 9
Buffalo 9
Munich 9
São Paulo 9
Falkenstein 8
London 8
Nanjing 8
Brussels 7
Phoenix 7
Shanghai 7
Vienna 7
Amsterdam 6
Bangkok 6
Düsseldorf 6
Jinan 6
Montreal 6
San Francisco 6
Tianjin 6
Toronto 6
Westminster 6
Biên Hòa 5
Florence 5
Guangzhou 5
Nanchang 5
Naples 5
Neuhofen an der Ybbs 5
Ottawa 5
Quận Bình Thạnh 5
Shenyang 5
Tongling 5
Bengaluru 4
Berlin 4
Bến Tre 4
Changsha 4
Chicago 4
Denver 4
Jakarta 4
Lahore 4
Medford 4
Newark 4
Olalla 4
Paris 4
Parma 4
Poplar 4
Quezon City 4
Redwood City 4
Rotterdam 4
Sofia 4
Verona 4
Wuhan 4
Zhengzhou 4
Ankara 3
Bühl 3
Bắc Ninh 3
Campi Bisenzio 3
Can Tho 3
Chennai 3
Totale 2.095
Nome #
Mutational burden of resectable pancreatic cancer, as determined by whole transcriptome and whole exome sequencing, predicts a poor prognosis. 239
Mutational burden of resectable pancreatic cancer by whole-transcriptome and whole-exome sequencing could predict a poor prognosis 231
Circulating tumor cells in genitourinary tumors 220
TERC and c-MYC COPY number gain in intraductal papillary mucinous neoplasms (IPMNs): promising biomarkers of progression to malignancy 220
Circulating microRNA biomarkers in melanoma and non-melanoma skin cancer 212
Anti-programmed cell death-1 and anti-programmed cell death ligand-1 immune-related liver diseases: from clinical pivotal studies to real-life experience 209
TERC AND MYC COPY NUMBER GAIN AS POWERFUL GENETIC MARKERS FOR INTRADUCTAL PAPILLARY NEOPLASMS OF THE PANCREAS 198
Peripheral nervous system adverse events associated with immune checkpoint inhibitors 174
Non-coding RNA dysregulation in skin cancers 164
Immunotherapy-refractory, EGFR overexpressing metastatic porocarcinoma responding to cetuximab 163
Osteoblastic bone response mimicking bone progression during treatment with pembrolizumab in advanced cutaneous melanoma 151
Emerging Novel Therapeutic Approaches for Treatment of Advanced Cutaneous Melanoma 146
Defining high-risk patients: beyond the 8the AJCC melanoma staging system 142
Organizing pneumonia after pancreatic cancer treatment with nab-paclitaxel and gemcitabine: a case report 129
Drug-induced photosensitivity during tebentafusp treatment for metastatic uveal melanoma: A newly described occurrence 115
Analysis of basal cell carcinomas' histological subtypes and relative response to vismodegib in six patients diagnosed with Gorlin–Goltz syndrome: A retrospective study 104
A new classification of upper gastrointestinal toxicity induced by immunotherapy: from endoscopic and pathological insights to clinical management 93
Cemiplimab-Induced alopecia areata 87
Clinical characteristics and treatment outcomes of non-V600 E/K BRAF mutant melanoma patients: A single-institution experience 86
Retreatment with sonidegib in a patient with multiple basal cell carcinomas and multiple comorbidities: a complex real-life scenario 82
Comparative assessment of early mortality risk upon immune checkpoint inhibitors alone or in combination with other agents across solid malignancies: a systematic review and meta-analysis 79
Neurological Manifestations as a Harbinger of Myocarditis in Patients Treated With Immune Checkpoint Inhibitors 76
Relatlimab and nivolumab in untreated advanced melanoma: insight into RELATIVITY 68
INfluenza Vaccine Indication during therapy with Immune checkpoint inhibitors: A transversal challenge. the INVIDIa study 61
Should Fertility Preservation Be Offered to Young Women with Melanoma Receiving Immune Checkpoint Inhibitors? A SWOT Analysis 53
Adjuvant therapy in renal cell carcinoma 38
Totale 3.540
Categoria #
all - tutte 10.534
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.534


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022247 0 6 6 7 15 16 8 16 14 60 49 50
2022/2023453 41 58 14 39 36 42 16 26 86 8 31 56
2023/2024211 21 46 15 26 17 29 11 17 4 11 11 3
2024/2025614 35 66 48 56 65 39 36 34 14 67 56 98
2025/20261.503 128 88 129 98 178 73 135 75 372 119 65 43
2026/2027105 54 51 0 0 0 0 0 0 0 0 0 0
Totale 3.540